Type I and Type III interferons display different dependency on mitogen-activated protein kinases to mount an antiviral state in the human gut

Intestinal epithelial cells (IECs) are constantly exposed to commensal flora and pathogen challenges. How IECs regulate their innate immune response to maintain gut homeostasis remains unclear. Interferons (IFNs) are cytokines produced during infections. While type I IFN receptors are ubiquitously e...

Full description

Saved in:
Bibliographic Details
Main Authors: Pervolaraki, Kalliopi (Author) , Stanifer, Megan (Author) , Kurzhals, Stefan (Author) , Senís Herrero, Elena (Author) , Grimm, Dirk (Author) , Schröder-Braunstein, Jutta (Author) , Boulant, Steeve (Author)
Format: Article (Journal)
Language:English
Published: 21 April 2017
In: Frontiers in immunology
Year: 2017, Volume: 8
ISSN:1664-3224
DOI:10.3389/fimmu.2017.00459
Online Access:Verlag, Volltext: http://dx.doi.org/10.3389/fimmu.2017.00459
Verlag, Volltext: https://www.frontiersin.org/articles/10.3389/fimmu.2017.00459/full
Get full text
Author Notes:Kalliopi Pervolaraki, Megan L. Stanifer, Stephanie Münchau, Lynnsey A. Renn, Dorothee Albrecht, Stefan Kurzhals, Elena Senís, Dirk Grimm, Jutta Schröder-Braunstein, Ronald L. Rabin, Steeve Boulant

MARC

LEADER 00000caa a2200000 c 4500
001 1577903609
003 DE-627
005 20230602111223.0
007 cr uuu---uuuuu
008 180724s2017 xx |||||o 00| ||eng c
024 7 |a 10.3389/fimmu.2017.00459  |2 doi 
035 |a (DE-627)1577903609 
035 |a (DE-576)507903609 
035 |a (DE-599)BSZ507903609 
035 |a (OCoLC)1341014407 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 32  |2 sdnb 
100 1 |a Pervolaraki, Kalliopi  |e VerfasserIn  |0 (DE-588)1163302384  |0 (DE-627)1027526926  |0 (DE-576)507903560  |4 aut 
245 1 0 |a Type I and Type III interferons display different dependency on mitogen-activated protein kinases to mount an antiviral state in the human gut  |c Kalliopi Pervolaraki, Megan L. Stanifer, Stephanie Münchau, Lynnsey A. Renn, Dorothee Albrecht, Stefan Kurzhals, Elena Senís, Dirk Grimm, Jutta Schröder-Braunstein, Ronald L. Rabin, Steeve Boulant 
264 1 |c 21 April 2017 
300 |a 16 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 24.07.2018 
520 |a Intestinal epithelial cells (IECs) are constantly exposed to commensal flora and pathogen challenges. How IECs regulate their innate immune response to maintain gut homeostasis remains unclear. Interferons (IFNs) are cytokines produced during infections. While type I IFN receptors are ubiquitously expressed, type III IFN receptors are expressed only on epithelial cells. This epithelium specificity strongly suggests exclusive functions at epithelial surfaces, but the relative roles of type I and III IFNs in the establishment of an antiviral innate immune response in human IECs are not clearly defined. Here, we used mini-gut organoids to define the functions of types I and III IFNs to protect the human gut against viral infection. We show that primary non-transformed human IECs, upon viral challenge, upregulate the expression of both type I and type III IFNs at the transcriptional level but only secrete type III IFN in the supernatant. However, human IECs respond to both type I and type III IFNs by producing IFN stimulated genes (ISGs) that in turn induce an antiviral state. Using genetic ablation of either type I or type III IFN receptors, we show that either IFN can independently restrict virus infection in human IECs. Importantly, we report, for the first-time, differences in the mechanisms by which each IFN establishes the antiviral state. Contrary to type I IFN, the antiviral activity induced by type III IFN is strongly dependent on the mitogen-activated protein kinases (MAPK) signaling pathway, suggesting a pathway used by type III IFNs that non-redundantly contributes to the antiviral state. In conclusion, we demonstrate that hIECs specifically regulate their innate immune response favoring type III IFN-mediated signaling which allows for efficient protection against pathogens without producing excessive inflammation. Our results strongly suggest that type III IFN constitutes the frontline of antiviral response in the human gut. We propose that mucosal surfaces, particularly the gastro-intestinal tract, have evolved to favor type III IFN-mediated response to pathogen infections as it allows for spatial segregation of signaling and moderate production of inflammatory signals which we propose are key to maintain gut homeostasis. 
650 4 |a antiviral immunity 
650 4 |a human gut microbiota 
650 4 |a IECs 
650 4 |a IFN-lambda 
650 4 |a IFN-β 
650 4 |a MAPKs 
650 4 |a mucosal immunity 
700 1 |a Stanifer, Megan  |e VerfasserIn  |0 (DE-588)1130687643  |0 (DE-627)884888835  |0 (DE-576)486922367  |4 aut 
700 1 |a Kurzhals, Stefan  |d 1983-  |e VerfasserIn  |0 (DE-588)1148774262  |0 (DE-627)1009175912  |0 (DE-576)496424602  |4 aut 
700 1 |a Senís Herrero, Elena  |e VerfasserIn  |0 (DE-588)1080250026  |0 (DE-627)844088617  |0 (DE-576)453431690  |4 aut 
700 1 |a Grimm, Dirk  |e VerfasserIn  |0 (DE-588)1016476671  |0 (DE-627)70553376X  |0 (DE-576)352260645  |4 aut 
700 1 |a Schröder-Braunstein, Jutta  |e VerfasserIn  |0 (DE-588)1100387021  |0 (DE-627)859344096  |0 (DE-576)469677821  |4 aut 
700 1 |a Boulant, Steeve  |e VerfasserIn  |0 (DE-588)1130687430  |0 (DE-627)884888509  |0 (DE-576)48692243X  |4 aut 
773 0 8 |i Enthalten in  |t Frontiers in immunology  |d Lausanne : Frontiers Media, 2010  |g 8(2017), Artikel-ID 459  |h Online-Ressource  |w (DE-627)657998354  |w (DE-600)2606827-8  |w (DE-576)343624834  |x 1664-3224  |7 nnas  |a Type I and Type III interferons display different dependency on mitogen-activated protein kinases to mount an antiviral state in the human gut 
773 1 8 |g volume:8  |g year:2017  |g elocationid:459  |g extent:16  |a Type I and Type III interferons display different dependency on mitogen-activated protein kinases to mount an antiviral state in the human gut 
856 4 0 |u http://dx.doi.org/10.3389/fimmu.2017.00459  |x Verlag  |x Resolving-System  |3 Volltext 
856 4 0 |u https://www.frontiersin.org/articles/10.3389/fimmu.2017.00459/full  |x Verlag  |3 Volltext 
951 |a AR 
992 |a 20180724 
993 |a Article 
994 |a 2017 
998 |g 1130687430  |a Boulant, Steeve  |m 1130687430:Boulant, Steeve  |d 910000  |d 911700  |d 700000  |d 718000  |e 910000PB1130687430  |e 911700PB1130687430  |e 700000PB1130687430  |e 718000PB1130687430  |k 0/910000/  |k 1/910000/911700/  |k 0/700000/  |k 1/700000/718000/  |p 11  |y j 
998 |g 1100387021  |a Schröder-Braunstein, Jutta  |m 1100387021:Schröder-Braunstein, Jutta  |d 910000  |d 911600  |e 910000PS1100387021  |e 911600PS1100387021  |k 0/910000/  |k 1/910000/911600/  |p 9 
998 |g 1016476671  |a Grimm, Dirk  |m 1016476671:Grimm, Dirk  |d 910000  |d 911700  |d 700000  |d 718000  |e 910000PG1016476671  |e 911700PG1016476671  |e 700000PG1016476671  |e 718000PG1016476671  |k 0/910000/  |k 1/910000/911700/  |k 0/700000/  |k 1/700000/718000/  |p 8 
998 |g 1080250026  |a Senís Herrero, Elena  |m 1080250026:Senís Herrero, Elena  |d 910000  |d 911700  |e 910000PS1080250026  |e 911700PS1080250026  |k 0/910000/  |k 1/910000/911700/  |p 7 
998 |g 1148774262  |a Kurzhals, Stefan  |m 1148774262:Kurzhals, Stefan  |d 910000  |d 911600  |e 910000PK1148774262  |e 911600PK1148774262  |k 0/910000/  |k 1/910000/911600/  |p 6 
998 |g 1130687643  |a Stanifer, Megan  |m 1130687643:Stanifer, Megan  |d 910000  |d 911700  |e 910000PS1130687643  |e 911700PS1130687643  |k 0/910000/  |k 1/910000/911700/  |p 2 
998 |g 1163302384  |a Pervolaraki, Kalliopi  |m 1163302384:Pervolaraki, Kalliopi  |d 910000  |d 911700  |e 910000PP1163302384  |e 911700PP1163302384  |k 0/910000/  |k 1/910000/911700/  |p 1  |x j 
999 |a KXP-PPN1577903609  |e 3019455731 
BIB |a Y 
SER |a journal 
JSO |a {"language":["eng"],"title":[{"title":"Type I and Type III interferons display different dependency on mitogen-activated protein kinases to mount an antiviral state in the human gut","title_sort":"Type I and Type III interferons display different dependency on mitogen-activated protein kinases to mount an antiviral state in the human gut"}],"person":[{"role":"aut","given":"Kalliopi","display":"Pervolaraki, Kalliopi","family":"Pervolaraki"},{"family":"Stanifer","given":"Megan","role":"aut","display":"Stanifer, Megan"},{"display":"Kurzhals, Stefan","given":"Stefan","role":"aut","family":"Kurzhals"},{"display":"Senís Herrero, Elena","given":"Elena","role":"aut","family":"Senís Herrero"},{"display":"Grimm, Dirk","role":"aut","given":"Dirk","family":"Grimm"},{"family":"Schröder-Braunstein","given":"Jutta","role":"aut","display":"Schröder-Braunstein, Jutta"},{"family":"Boulant","role":"aut","given":"Steeve","display":"Boulant, Steeve"}],"name":{"displayForm":["Kalliopi Pervolaraki, Megan L. Stanifer, Stephanie Münchau, Lynnsey A. Renn, Dorothee Albrecht, Stefan Kurzhals, Elena Senís, Dirk Grimm, Jutta Schröder-Braunstein, Ronald L. Rabin, Steeve Boulant"]},"relHost":[{"pubHistory":["1.2010 -"],"language":["eng"],"part":{"extent":"16","volume":"8","text":"8(2017), Artikel-ID 459","year":"2017"},"title":[{"title_sort":"Frontiers in immunology","title":"Frontiers in immunology"}],"type":{"bibl":"periodical","media":"Online-Ressource"},"recId":"657998354","origin":[{"publisherPlace":"Lausanne","dateIssuedDisp":"2010-","publisher":"Frontiers Media","dateIssuedKey":"2010"}],"note":["Gesehen am 07.11.13"],"disp":"Type I and Type III interferons display different dependency on mitogen-activated protein kinases to mount an antiviral state in the human gutFrontiers in immunology","id":{"zdb":["2606827-8"],"issn":["1664-3224"],"eki":["657998354"]},"physDesc":[{"extent":"Online-Ressource"}]}],"note":["Gesehen am 24.07.2018"],"physDesc":[{"extent":"16 S."}],"id":{"eki":["1577903609"],"doi":["10.3389/fimmu.2017.00459"]},"type":{"bibl":"article-journal","media":"Online-Ressource"},"origin":[{"dateIssuedKey":"2017","dateIssuedDisp":"21 April 2017"}],"recId":"1577903609"} 
SRT |a PERVOLARAKTYPEIANDTY2120